about
Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?Homology modelling of transferrin-binding protein A from Neisseria meningitidis.Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens.Rapid characterization of outer-membrane proteins in Neisseria lactamica by SELDI-TOF-MS (surface-enhanced laser desorption ionization-time-of-flight MS) for use in a meningococcal vaccine.Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort.Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvacAnti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infectionCooperative role for tetraspanins in adhesin-mediated attachment of bacterial species to human epithelial cellsImmunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies.Relationships between Mucosal Antibodies, Non-Typeable Haemophilus influenzae (NTHi) Infection and Airway Inflammation in COPD.Infection with an avirulent phoP mutant of Neisseria meningitidis confers broad cross-reactive immunity.Structural, Functional, and Immunogenic Insights on Cu,Zn Superoxide Dismutase Pathogenic Virulence Factors from Neisseria meningitidis and Brucella abortus.Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease.Placental transfer of anti-group B Streptococcus immunoglobulin G antibody subclasses from HIV-infected and uninfected women to their uninfected infants.Risk factors for Group B Streptococcus colonisation and disease in Gambian women and their infants.Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential.Bexsero: a multicomponent vaccine for prevention of meningococcal disease.Bordetella pertussis fimbriae (Fim): relevance for vaccines.Neisseria lactamica Y92-1009 complete genome sequence.Nasal Inoculation of the Commensal Neisseria lactamica Inhibits Carriage of Neisseria meningitidis by Young Adults: A Controlled Human Infection Study.Meningococcal transferrin-binding proteins A and B show cooperation in their binding kinetics for human transferrin.Purified meningococcal transferrin-binding protein B interacts with a secondary, strain-specific, binding site in the N-terminal lobe of human transferrin.Identification of vaccine antigens using integrated proteomic analyses of surface immunogens from serogroup B Neisseria meningitidis.Neisserial outer membrane vesicles bind the coinhibitory receptor carcinoembryonic antigen-related cellular adhesion molecule 1 and suppress CD4+ T lymphocyte function.Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model.Expression and purification of functional recombinant meningococcal transferrin-binding protein A.Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant.Formulation and characterisation of Bordetella pertussis fimbriae as novel carrier proteins for Hib conjugate vaccines.Assessment of vaccine potential of the Neisseria-specific protein NMB0938.Differential binding of apo and holo human transferrin to meningococci and co-localisation of the transferrin-binding proteins (TbpA and TbpB).Identification by genomic immunization of a pool of DNA vaccine candidates that confer protective immunity in mice against Neisseria meningitidis serogroup B.SIgA, TGF-β1, IL-10, and TNFα in Colostrum Are Associated with Infant Group B Streptococcus Colonization.Correction to: Neisseria lactamica Y92-1009 complete genome sequence.Absence of mucosal immunity in the human upper respiratory tract to the commensal bacteria Neisseria lactamica but not pathogenic Neisseria meningitidis during the peak age of nasopharyngeal carriage.Plasticity of fimbrial genotype and serotype within populations of Bordetella pertussis: analysis by paired flow cytometry and genome sequencing.16th International Pathogenic Neisseria Conference: recent progress towards effective meningococcal disease vaccines.Neisseria lactamica selectively induces mitogenic proliferation of the naive B cell pool via cell surface Ig.Characterisation and immune responses to meningococcal recombinant porin complexes incorporated into liposomes.Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis.
P50
Q30150784-82712A25-F5EB-4931-8656-A412CDA417A5Q30160272-7007A6B7-6FE2-40E2-9AD2-DE2B709DBBBBQ30230636-D0F54B2E-2311-4594-A1F0-9701DB5AC229Q31106183-7D1A732C-FCA8-41D9-A60B-7481017A434CQ33689195-5D92B2F3-0977-442E-B136-7F9A0D515875Q34975624-890CCD00-5C58-4D6B-897E-87D66F3D7C90Q35042473-3342537F-3DB4-47D4-8300-EE2E43FE617AQ35075781-6F4A86E1-5DC7-4E83-B40D-57A374311438Q35217627-BE3320C1-79C9-485B-9B09-BC0E9DA56928Q36206898-53387EAC-ADC1-4BA9-985D-6E615AB55D93Q36227890-FE25F47D-E229-41B2-BEC2-43AC78398412Q36297476-2233E944-1BEF-4E8D-9175-8EEBC1A69B35Q36378615-972FB156-4632-462C-97D4-AFF8D51093F6Q36458498-748A18CF-BD3A-4BB8-8FB8-995506E62FECQ36624991-ACEBBE11-F78C-4A4D-BE03-CB750165B677Q37545016-CD179DD6-5F66-4049-A08B-E3FE0BA9600BQ37582852-E7E2DC43-3AC5-4B57-8EC0-85286CB67045Q37994540-B476219C-1003-4DB0-8AB8-029B06301671Q38237862-9A3D44A6-8EA5-41CE-B6BB-BEF572383DDCQ38645492-06845F21-B8DD-4465-BD49-4C05D3DDADF2Q38967874-830D4330-A474-4501-94EE-C8D7EF5A9C11Q40993333-3E537B8F-5D91-4EA3-8153-84FA43A0EA8FQ42070145-AAA25323-088F-4BA8-83AF-90980E739D9FQ42227353-B2D460F9-59E2-4A84-B52B-F5C43097FE58Q42413093-07DDB530-137C-4038-8050-A6181E016C19Q42650053-9D2206BD-5DA9-427E-A39B-CFED59894328Q43001885-108B8D00-5836-4DC4-8FB7-D18A4889AC81Q43441551-2F9F61B1-C0CC-4866-BE40-5E0D94335F90Q43604614-53B77450-C933-4957-A885-1F3C8101FB98Q43992230-D40F0BE8-561C-4B41-AD2D-29B70AF0F515Q44345271-3EF6C2BC-6125-454E-A550-FE6E07355135Q44695129-029A5545-0F6F-4A56-A98B-136FA7AC338DQ46301683-A7AAC20A-B4AC-4863-BB4A-5BED46C2A8EAQ50323798-4ABBD0AE-BEED-4974-9731-2CC7FC912F79Q51182276-8952D714-0D7C-4938-A2A7-EAEFAC598965Q51710453-DDE72D46-3454-4E85-BC0C-B213415E8286Q53189030-206FD475-4725-44E3-9256-DEDB28C0B1A1Q53306274-776409F6-6127-4B7E-97B0-9FBD1207AC93Q54169304-13D351AD-AAB6-4641-BE97-524CE29CBF2FQ54315906-D76A2B62-34E2-4FA1-8474-69CE11BBA1B4
P50
description
researcher
@en
wetenschapper
@nl
name
A R Gorringe
@en
A R Gorringe
@nl
type
label
A R Gorringe
@en
A R Gorringe
@nl
prefLabel
A R Gorringe
@en
A R Gorringe
@nl
P106
P31
P496
0000-0003-2193-7954